SoftBank, Bristol Myers Squibb and Hitachi were among Arsenal Biosciences’ $220m round while MegaChips led a $140m round for Morse Micro.

M&A Pharmaceutical firm Roche has agreed to acquire a portfolio company, Good Therapeutics, which is a US-based self-regulating therapy developer, for $250m in cash and additional earnouts. The company had secured more than $30m in funding from the corporate’s Roche Venture Fund as well as RiverVest Venture Partners, 3×5 Partners, Digitalis Ventures and Codon Capital.…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.